ZLAB
Zai Lab Limited
$18.60
-5.89%
2026-05-08
About Zai Lab Limited
Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases. Its commercial products include Zejula, an orally administered poly (ADP-ribose) polymerase 1/2 inhibitor for treating ovarian cancer; VYVGART, a human IgG1 antibody fragment for generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy; NUZYRA for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections; Optune for glioblastoma multiforme; Qinlock for gastrointestinal stromal tumors; Xacduro for treating hospital-acquired and ventilator-associated bacterial pneumonia caused by a cinetobacter baumannii-calcoaceticus complex; and Augtyro for the treatment of ROS proto-oncogene 1 and non-small cell lung cancer. The company has a strategic collaboration with Tesaro, Inc., NovoCure Ltd., Deciphera Pharmaceuticals, LLC, Paratek Bermuda Ltd., argent BV, Turning Point Therapeutics, Inc., Entasis Therapeutics Holdings Inc., Karuna Therapeutics, Inc., Pfizer Inc., Amgen Inc., and with Boehringer Ingelheim GmbH. The company was incorporated in 2013 and is based in Pudong, China.
Key Fundamentals
Forward P/E
-12.91
EPS (TTM)
$-1.70
ROE
-22.6%
Revenue Growth (YoY)
17.0%
Profit Margin
-38.1%
Debt/Equity
31.34
Price/Book
2.97
Beta
0.84
Market Cap
$2.16B
Avg Volume (10D)
591K
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$25.28
60D Low
$17.10
Avg Volume
701K
Latest Close
$18.60
Get breakout alerts for ZLAB
Sign up for Breakout Scanner to receive daily notifications when ZLAB triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Zai Lab Limited (ZLAB) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors ZLAB daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. ZLAB operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.